Intellectual property theft
Your compounds, sequences, and processes are the whole business. Competitors and nation‑states would rather steal that IP than fund their own.
Biotech & Life Sciences
Your research is the company.
A single compound, sequence, or dataset can represent a decade of work and the entire competitive edge behind your valuation. We protect that research from the espionage and quiet, long‑game attacks that target life sciences — and keep your data ready for the regulators.
Research IP protection Trial data integrity 21 CFR Part 11 & GxP
The threat landscape
When your R&D is the target
Life sciences faces a different kind of adversary — patient, well‑funded, and after your research rather than a quick payout.
Long-dwell APTs
Advanced attackers break in quietly and stay for months, slowly siphoning research. Without monitoring, you may never know they were there.
Trial data integrity
Clinical trial data has to be trustworthy for regulators. Tampering, loss, or a broken audit trail can jeopardize a submission entirely.
Legacy lab systems
Sequencers, analyzers, and LIMS often run software that can’t be patched — specialized, expensive, and quietly exposed.
Collaboration & CRO risk
You share data with CROs, academic partners, and manufacturers. Each connection is a door — and a breach at any of them reaches you.
Regulatory exposure
FDA 21 CFR Part 11 and GxP set strict rules for electronic records and data integrity — and falling short can stall an approval.
Years.
A decade of research, stolen in seconds
The value in a life sciences company is the work — years of experiments, data, and discovery that can’t be redone overnight. An attacker who copies it doesn’t slow you down; they hand your competitive advantage to someone else, often before you even realize it’s gone. Protecting that research isn’t an IT concern. It’s existential.
The core challenge
The threat that waits, not the one that shouts
Ransomware wants you to notice — it locks the door and demands payment. The attacks that hurt life sciences most do the opposite: they stay silent, blend in, and quietly copy your research over weeks or months.
That changes what good security looks like. It’s not just about keeping attackers out — it’s about detecting the ones who get in, watching for data that shouldn’t be leaving, and knowing your research is where it should be. Prevention plus continuous detection is the only real defense against a patient adversary.
Keep them out
Harden the perimeter, close the exploitable paths, and lock down access to the systems that hold your research.
Necessary · but they will still try, and some get in
Catch the ones who do
Monitor continuously for intrusions and unusual data movement, so a quiet attacker is found in hours — not after the damage.
The difference · detection is what stops slow theft
How we help
Protection built around your IP
We bring our full practice to your research environment — tuned for the long game, where the goal is quiet theft, not a loud ransom.
24/7 monitoring & exfiltration detection
Continuous eyes on your research systems and data flows — so a long‑dwell intruder or a quiet outbound transfer gets caught fast.
Explore SOC & MDRPenetration testing
We find the paths an attacker would take to your crown‑jewel research — before an adversary does — and show you how to close them.
Explore VAPT21 CFR Part 11 & GxP readiness
We put the access controls, audit trails, and safeguards in place that FDA electronic‑records rules and data integrity expectations demand.
Explore complianceIncident response & investigation
If research is breached, we move fast to contain it, determine exactly what was taken, and help you understand your exposure.
Explore incident response Standards that apply
The rules life sciences has to meet
Between FDA regulation, quality systems, and the security questionnaires partners and investors send, we map your controls to what matters — and get you ready to prove it.
21 CFR Part 11
Electronic records & signatures
GxP
Data integrity (GLP/GMP/GCP)
NIST CSF
Security baseline
ISO 27001
Global & investor deals
Why StrikeProof
We defend the long game
The adversaries targeting life sciences are patient and well‑funded, and they’re after your research, not a ransom. Defending against that takes more than a firewall — it takes offense‑informed testing and relentless detection.
- Detection‑focused. We watch for the quiet intruder and the data that shouldn’t be leaving.
- IP‑centric. We build protection around your crown‑jewel research, not a generic checklist.
- Regulation‑fluent. Part 11 and GxP done as real security, not just documentation.
- One team, end to end. Testing, monitoring, response, and compliance — without juggling vendors.
IP
Research protected & monitored
24/7
Exfiltration & intrusion detection
Part 11
FDA & GxP readiness
50
States served — nationwide
Biotech FAQ
Common questions
Why is biotech such a target for intellectual property theft?
Because the research is the company. A single compound, sequence, or dataset can represent a decade of work and the entire competitive advantage behind your valuation. That makes life sciences a top target for industrial espionage and nation‑state actors, who would rather steal years of R&D than fund their own. The payoff is enormous, so the effort they invest is too.
What is an advanced persistent threat, and why does it matter to us?
An advanced persistent threat (APT) is a well‑resourced attacker who breaks in quietly and stays hidden for months, slowly exfiltrating data rather than causing obvious damage. Biotech is a favorite target because the goal is theft of research, not a quick ransom. The danger is that without continuous monitoring, you may not know they were ever there — until your work shows up somewhere else.
Can you help with FDA 21 CFR Part 11 and GxP data integrity?
Yes. Electronic records and signatures in regulated life sciences must meet FDA 21 CFR Part 11, and your quality systems have to preserve data integrity under GxP expectations. We help you put the access controls, audit trails, and security safeguards in place that these regulations require — and make sure they hold up to both an auditor and a real attacker.
Our lab instruments and LIMS run on old software. Can you secure them?
Yes. Sequencers, analyzers, and laboratory information management systems often run software that can’t be easily patched or replaced. When a system can’t be updated, we protect it another way — using network segmentation, monitoring, and access controls to isolate it, so vulnerable lab equipment can’t be used as a way into your research environment.
We collaborate with CROs and academic partners. Doesn’t that increase our risk?
It does, and it’s unavoidable in this field. Every contract research organization, academic collaborator, and manufacturing partner you share data with expands your attack surface, and a breach at any of them can expose your research. We help you assess that third‑party risk, put the right controls and agreements around shared data, and monitor for exposure across those connections.
Protect the research you’ve spent years building.
Let’s talk about defending your IP, your trial data, and your lab — from the espionage that targets life sciences. No jargon, no scare tactics — just a clear look at where you stand.